Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer: A Commentary
Cancer Plus · 2020
DOI: 10.18063/cp.v2i3.293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Plus, 2020. Verfasst von Kashif Hussain und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This commentary refers to our recently published article “Association of long-term consumption of repeatedly heated mix vegetable oils (RHMVO) in different doses and hepatic toxicity through fat accumulation.” As highlighted in this article, long-term intake of RHMVO leads to fat accumulation in hepatocytes, oxidative stress, and lipid peroxidation. Several studies have illustrated the negative effect of RHMVO on human health. In this commentary, we considered other recent evidence reporting the carcinogenic and mutagenic potential of RHMVO. Furthermore, we emphasized the unique and easy to perform parameters to measure oxidative stress, lipid peroxidation, fat accumulation, and increased inflammation in hepatocytes to identify progression toward hepatic carcinoma. Our commentary is also intended to further highlight the necessity of developing food policies and regularity bodies as an approach to minimize the increasing trend of cancer incidence.
Zitieren
APA
Hussain, K., Siddiq, A., Naz, Z., & Ambreen, G. (2020). Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer: A Commentary. Cancer Plus. https://doi.org/10.18063/cp.v2i3.293
Vancouver
Hussain K, Siddiq A, Naz Z, Ambreen G. Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer: A Commentary. Cancer Plus. 2020. doi:10.18063/cp.v2i3.293
BibTeX
@article{Hussain2020,
author = {Hussain, Kashif and Siddiq, Afshan and Naz, Zara and Ambreen, Gul},
title = {Association of Repeatedly Heated Oil-Induced Hepatic Fat Accumulation and Development of Cancer: A Commentary},
journal = {Cancer Plus},
year = {2020},
doi = {10.18063/cp.v2i3.293}
}
EUVIMED